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　 In  this  study,  we  evaluated  if  the  implantation  of 
allogenic  adipose-derived  stem  cells  (ASCs)  improved 
neurological function in a canine spinal cord injury model. 
Eleven adult dogs were assigned to three groups according 
to treatment after spinal cord injury by epidural balloon 
compression: C group (no ASCs treatment as control), V 
group  (vehicle  treatment  with  PBS),  and  ASC  group 
(ASCs treatment). ASCs or vehicle were injected directly 
into the injured site 1 week after spinal cord injury. Pelvic 
limb function after transplantation was evaluated by Olby 
score. Magnetic resonance imaging, somatosensory evoked 
potential (SEP), histopathologic and immunohistichemical 
examinations  were  also  performed.  Olby  scores  in  the 
ASC group increased from 2 weeks after transplantation 
and were significantly higher than C and V groups until 8 
weeks  (p  ＜  0.05).  However,  there  were  no  significant 
differences between the C and V groups. Nerve conduction 
velocity based on SEP was significantly improved in the 
ASC  group  compared  to  C  and  V  groups  (p  ＜  0.05). 
Positive areas for Luxol fast blue staining were located at 
the injured site in the ASC group. Also, GFAP, Tuj-1 and 
NF160  were  observed  immunohistochemically  in  cells 
derived  from  implanted  ASCs.  These  results  suggested 
that  improvement  in  neurological  function  by  the 
transplantation of ASCs in dogs with spinal cord injury 
may  be  partially  due  to  the  neural  differentiation  of 
implanted stem cells.
Keywords: adipose-derived stem cells, dog, spinal cord injury, 
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Introduction 
Central nervous system regeneration is highly limited 
after injury. Spinal cord injury (SCI) leads to cell death, 
particularly in neurons, oligodendrocytes, astrocytes, and 
precursor cells [12]. Any cavities and cysts resulting from 
this cell death and loss may interrupt axonal tracts. SCI 
culminates in glial scarring, a multifactorial process 
involving reactive astrocytes, glial progenitors, microglia, 
macrophages, fibroblasts, and Schwann cells [15]. Such 
scars are often oriented perpendicular to the neuraxis, 
contain transmembrane molecular inhibitors of axon growth, 
and appear impenetrable [34]. Neuronal phenotypes are 
not generated following SCI [42] and apparent lack of 
regenerative capacities of the adult spinal cords could result 
from the neurogenesis inhibitors of myelin-derived proteins, 
glial scar and extracellular matrix-derived factor [35].
Cell transplantation therapy using adult stem cells has 
recently been identified as a potential treatment for SCI [2]. 
Such cells can differentiate into appropriate neuronal 
phenotypes in ischemic or damaged brain and spinal cord 
[18]. Adipose tissue compartments are a particularly useful 
source of mesenchymal stem cells (MSCs) due to ease of 
harvest, clonogenic potential, and robust proliferative 
capacity [7]. Adipose-derived stem cells (ASCs) can 
differentiate into adipocyte, chondrocyte, myocyte, osteoblast, 
and even neural lineages [11]. 
ASCs may have therapeutic potential for neurological 
disorders, and functional recovery after transplantation of 
ASCs into the areas of spinal cord injury in vivo was 
reported in rodent models of SCI [18]. Rodent spinal cords 
are smaller than canine cords and are also anatomically 
distinct in areas such as the extrapyramidal tract, therefore 
the rodent model is not suitable for detailed physical 
analyses or accurate evaluation of recovery [10]. Although 274    Hak-Hyun Ryu et al.
it was reported that umbilical cord blood derived MSCs 
was effective in canine SCI model, there was little 
histological evidence of spinal cord tissue regeneration 
[22]. In this study, we examined whether canine ASCs 
could survive and integrate into neural cells and the 
effectiveness of canine ASCs on the improvement of 
neurological function in canine SCI model. 
Materials and Methods
Animals
Eleven healthy adult mixed-breed dogs (4.6 ± 0.4 kg) 
were used. Applicable institutional and governmental 
regulations concerning the ethical use of animals were 
followed during the course of this research. This investigation 
was performed in accordance with the guidelines of the 
“Guide for the Care and Use of Laboratory Animals” of 
Seoul National University. SCI was induced by epidural 
ballon compression. The dogs were randomly assigned to 
3 groups based on post-SCI treatment (31): Group C, 
control group with no ASCs transplantation (n = 3); Group 
V, vehicle group with phosphate-buffered saline (PBS) 
injection (n = 3); Group ASC, group with transplantation 
of allogenic ASCs into the site of SCI (n = 5).
Isolation and culture of ASCs
Adipose tissue was aseptically collected from the 
subcutaneous fat of a 2-year-old experimental dog under 
anesthesia. Tissues were washed extensively with PBS, 
minced and digested with collagenase type I (1 mg/mL; 
Sigma, USA) at 37
oC for 2 h [16]. After washing with PBS 
and centrifuging at 4
oC, pellets of stromal vascular fraction 
(SVF) were resuspended, filtered through 100 μm nylon 
mesh and incubated overnight in DMEM with 10% fetal 
bovine serum (FBS; Gibco BRL, USA) at 37ºC with 5% 
humidified CO2. Unattached cells and residual non-adherent 
red blood cells were removed after 24 h by washing with 
PBS, and cell medium was exchanged with Keratinocyte- 
SFM (Gibco BRL, USA). The medium was supplemented 
with human recombinant epidermal growth factor (rEGF, 5 
ng/mL; Gibco BRL, USA), bovine pituitary extract (50 μg/ 
mL; Gibco BRL, USA), 2 mM N-acetyl-L-cysteine (NAC; 
Sigma, USA), 0.2 mM L- ascorbic acid 2-phosphate (Asc 
2P; Sigma, USA), insulin (5 μg/mL; Sigma-Aldrich, USA), 
hydrocortisone (74 ng/mL; Sigma-Aldrich, USA). Medium 
was changed at 48 h intervals until the cells became 
confluent. After cells reached 90% confluence, they were 
trypsinized and stored in liquid nitrogen or subcultured at 
a density of 10,000 cells/cm
2 (passage 1). Cells were 
passage repeatedly after achieving a density of 80∼90% 
(approximately 7 days in culture) until passage 8. 
Differentiation test of ASCs
ASCs were differentiated in culture under the conditions 
described below. 
Adipogenic differentiation: ASCs were initially cultured 
and propagated up to 80∼90% confluence in K-NAC 
medium containing 5% FBS and then shifted to adipogenic 
medium [DMEM high-glucose medium with 10% FBS, 10 
μg/mL insulin (Sigma-Aldrich, USA), 1 μM dexamethasone 
(Sigma-Aldrich, USA), 0.2 mM indomethacin (Sigma- 
Aldrich, USA), and 0.5 mM isobutylmethylxanthine (Sigma- 
Aldrich, USA)] for 3 days, then to DMEM high-glucose 
medium with 10% FBS, 10 μg/mL insulin (Sigma-Aldrich, 
USA) for 4 days. This procedures repeated 3 times for 21 
days [13]. The accumulation of neutral lipids was detected 
by staining ASCs in a solution of 0.5% Oil red O.
Osteogenic differentiation: ASCs were initially cultured 
and propagated up to 70% confluence in K-NAC medium 
containing 5% FBS and then shifted to osteogenic medium 
[DMEM low-glucose medium with 10% FBS, 0.1 μM 
dexamethasone (Sigma-Aldrich, USA), 50 μM l-Ascorbate- 
2-phosphate (Sigma-Aldrich, USA), and 10 mM beta- 
glycerophosphate (Sigma-Aldrich, USA)] for 3 weeks [14]. 
Mineralization was assessed by staining ASCs with 40 mM 
Alizarin red S (pH 4.1).
Neurogenic differentiation: Neurogenic differentiation 
was induced by culturing ASCs in preinduction medium 
[DMEM low-glucose medium supplemented with 10% 
FBS and 1 mM b-mercaptoethanol (Sigma-Aldrich, USA)] 
for 24 h. After preinduction, the cells were induced for up 
to 5 h in neurogenic medium [DMEM with 100 μM 
butylated hydroxyanisol (Sigma-Aldrich, USA) and 1% 
DMSO (Sigma-Aldrich, USA)] [39]. The cells were 
analyzed by immunofluorescence staining for the expression 
of MAP2 (neuronal lineage) and Oct4 (pluripotent stem 
cell marker) [16]. ASCs were grown on four-well Lab-Tek 
slides (Nalge Nunc, USA). After blocking for 2 h in PBS 
containing 10% normal goat serum (Zymed Laboratories, 
USA), slides were incubated for 5 h at 4
oC with anti- 
MAP2 rabbit polyclonal (Chemicon International, USA) 
and anti-Oct4 rabbit polyclonal (Santa Cruz Biotechnology, 
USA) antibodies diluted in PBS. Slides were then washed 
3 times in PBS and incubated in TRITC goat anti-rabbit 
secondary antibody (BD Biosciences, USA) for 1 h at room 
temperature. Slides were washed 3 times in PBS and 
mounted. For the negative control, primary antibodies 
were omitted. 
Characterization of surface markers of ASCs
ASCs were examined for surface markers using Flow 
Cytometry [16]. The following antigens were purchased 
from VMRD (USA) unless otherwise indicated. The first 
passage of ASCs were analyzed for canine major 
histocompatibility complex (MHC)-class I (#H58A), 
MHC-class II (#CAT82A), histocompatibility locus 
antigen (HLA)-DR (#TH14B), pan-lymphocyte (#DH52A), 
B lymphocyte (#F46A), neutrophil (#CADO48A), CD4 Transplantation of ASCs in spinal cord injury    275
Fig. 1. Adipogenic and osteogenic differentiation of canine 
adipose-derived stem cells (ASCs). A: ASCs cultured in DMEM
+ 10% FBS media (control media), not stained by Oil red O. B: 
Oil red O stained after 3 weeks incubation at adipogenic media. 
C: ASCs cultured in control media, not stained with Alizarin red 
S. D: Intense Alizarin red S stained after 3 weeks incubation at 
osteogenic media and confirmed calcium deposition. A and B: 
Oil red O stain, C and D: Alizarin red S stain, ×100.
Fig. 2. Green fluorescence protein (GFP) labeled canine 
adipose-derived stem cells (ASCs).  (A) Typical morphological 
feature of canine ASCs. (B) Green fluorescence was identified in
ASCs at 48 h after transfection. ×100.
(#DH29A), CD8 (#CADO46A), CD44 (#BAG40Am), 
CD45-like (#CADO18A), CD90 (#DH24A), CD14 
(#CAM36A), CD3 (#MCA1774; AbD Serotec, USA), 
CD11c (#MCA1778S; AbD Serotec, USA) and CD34 
(#1H6; Becton, Dickinson and Company, USA). The 
seventh passage of ASCs were trypsinized, centrifuged 
and resuspended to concentration of about 5 × 10
5 cells for 
each test. Thus, 30 μL each of a prediluted PE-conjugated 
mouse anti-dog CD14 (#CAM46A), a PE-conjugated 
mouse anti-dog CD34 (MCA2411F; AbD Serotec, USA), 
a PE-conjugated mouse anti-dog CD45- like (CADO18A), 
a PE-conjugated rat anti-dog CD44 (ab19622; Abcam, UK), 
a PE-conjugated mouse anti-dog CD90 (DH2A) and a 
FITC-conjugated mouse anti-human CD105 (555690; BD 
Biosciences, USA) antibody was used in individual test. 
Negative control staining was performed using a FITC- 
conjugated mouse IgG1 isotype and a PE-conjugated mouse 
IgG1 isotype antibody respective the primary antibodies.
Transfection with green fluorescence protein (GFP) 
gene
Some cells were infected with a lentivirus-vector labeled 
GFP gene. Lentivirus was generated with ViraPower 
Lentiviral packaging Mix (Invitrogen, USA). Lipofectamine 
2000 (Invitrogen, USA) was used for transfection of SHC003 
MISSION TurboGFP control vector (Sigma, USA) to 
293FT cells (Invitrogen, USA). Cell culture media was 
changed the day after transfection and supernatant was 
harvested at 48 and 72 h after transfection. Viral supernatant 
was filtered using 0.4 μm pore filter (Invitrogen, USA). 
ASCs were transfected with TurboGFP- lentivirus about 15 
multiplicity of infection (MOI). Polybrene (Sigma, USA) 
was added to cell culture media at a final concentration of 
6 μg/mL. Cell culture media was changed the day after 
transfection with fresh culture media and green fluorescence 
was identified in cytoplasm of cells 48 h after transfection 
with a fluorescent microscope (Fig. 2B).
Induction of spinal cord injury 
Spinal cords of the experimental dogs under general 
anesthesia were compressed by epidural ballon catheter for 
12 h and resulted in SCI [22]. A fentanyl patch (Durogesic 
D-trans patch 25 mcg/h 4.2 mg/10.5 cm
2; Alza Ireland, 
Ireland) was used for analgesia 24 h before the operation. 
Cefazolin sodium (20 mg/kg; Chong Kun Dang Pharm, 
Korea) was given intravenously (IV) as a prophylactic 
antibiotic. Atropine sulfate (0.03 mg/kg; Je Il Pharm, Korea) 
was administered. The dogs were sedated with the IV 
administration of diazepam (Dong Wha Pharm, Korea) at a 
dose of 0.2 mg/kg, immediately followed by intravenous 
morphine (Ha Na Pharm, Korea) at 0.3 mg/kg. The dogs 
were induced with the IV administration of propofol (Ha 
Na Pharm, Korea) at 6 mg/kg. Anesthesia was maintained 
by 2% isoflurane (Ilisung, Korea) in oxygen. The minimum 
alveolar concentration was about 1.5. A multiparameter 
anesthetic monitor (Datex-Ohmeda, Denmark) was used to 
monitor physiologic measures, including rectal temperature, 
oxygen saturation, end tidal CO2, electrocardiogram, 
anesthetic agent concentration and blood pressure.
Following anesthetic stabilization, a mini-hemilaminectomy 
procedure was performed using a median approach to L4. 
A 3 to 5 mm hole was created in the left vertebral lamina at 
L4 using a high-speed pneumatic burr. A 3-French 
embolectomy catheter (Sorin Biomedica, Italy) was inserted 
into the hole at L4. A balloon was advanced, under 
fluoroscopic guidance, until the tip of the catheter reach the 
cranial margin of the L1 vertebral body. The balloon was 
inflated with a 50：50 solution of contrast agent (Omnipaque; 
Amersham Health, Ireland) and saline at a dose of 40 
μL/kg body weight for 12 h. It took approximately 30 min 276    Hak-Hyun Ryu et al.
to induce SCI. The balloon catheter was fixed with a Chinese 
finger type suture and removed after 12 h. All dogs were 
administrated analgesics by continuous rate infusion for 18 
h after skin closure. Post-operative analgesics contained 
morphine (Ha Na Pharm, Korea) at 0.15 mg/kg/h, lidocaine 
HCl (Dai Han Pharm, Korea) at 2 mg/kg/h and ketamine 
HCl (Yuhan Pharm, Korea) at 0.3 mg/kg/h [26]. After the 
operation, dogs were bandaged, monitored in the intensive 
care unit and the degree of pain assessed at 30 min intervals. 
The dogs with some overt signs of discomfort were given 
IV morphine at 0.2 mg/kg additionally. 
Suture materials were removed after 10 days. Dogs were 
fed with a nutritionally balanced feed twice a day and if 
necessary, manual bladder expression was performed at 
least three times daily until voluntary urination was 
established. The general condition of the dogs and their 
neurological status was monitored twice daily during the 
time of the study and there were no complications except 
for mild cystitis and muscle atrophy of hind limbs. Two 
dogs had a seroma in the surgical site and recovered 
spontaneously after 2 weeks. 
Transplantation of ASCs
ASCs were transplanted 1 week after experimentally- 
induced SCI. Group C did not receive media or any 
transplanted cells. For group V, the injured site was 
exposed by dorsal laminectomy and 150 μL of PBS was 
injected into the spinal cord at 3 locations to depths of 3 
mm using a 30 gauge needle (middle of the injury site, 
proximal and distal margins). For group ASC, 1 × 10
6 of 
prepared cells suspended in 150 μL PBS were injected into 
the SCI site in same fashion as group V. One dog in the 
ASC group was injected with GFP-labeled ASCs. 
Behavioral assessments
Using a 15-point scoring system (Olby score), the dogs’ 
gaits were independently scored from videotapes by 2 
separate individuals who were blinded to the experimental 
conditions [37]. Mean scores at 1, 3, 5 and 9 weeks after 
SCI were calculated.
Somatosensory evoked potential assessments
Somatosensory evoked potentials (SEP) were measured 
using a Neuropack 2 (Nihon Kohden, Japan) and two 
subdermal channels at 1, 5, and 9 weeks after the cell 
transplantation. Channel 1 was installed at the subdermal 
region at the midline between the sixth and seventh lumbar 
vertebrae (L6-L7) and channel 2 was installed between the 
tenth and eleventh thoracic vertebrae (T10-T11) using 
platinum grass stimulating electrode needle (Astro-Med, 
USA). The posterior tibial nerve was stimulated for 0.2 
msec, with 2 Hz and 3 mA [41]. The latency response was 
converted into velocity as a measure of spinal cord 
dysfunction. The spinal conduction velocity from the 6th 
lumbar (L) vertebra to the 10th thoracic (T) vertebra was 
calculated by the following equation: Conduction velocity 
(m/sec) = [distance between 2 points (cm)/latency difference 
(msec)] × 10. 
Magnetic resonance images 
Magnetic resonance image (MRI) was performed using a 
0.2 Tesla Magnet scanner (Esaote, Italy). A majority of the 
obtained images were interleaved at 5.0 mm with a slice 
thickness of 5.0 mm. The repetition time (TR) and time to 
echo (TE) were adjusted. T1-weighted (TR/TE = 540/26 
msec, T1W) and T2-weighted (TR/TE = 380/90 msec, 
T2W) echo images were obtained. All dogs in each group 
were examined and the SCI lesions were expressed in T2W 
sagittal planes at 5 and 9 weeks after the injury.
Histopathological and immunohistochemical assessment
All dogs were euthanized 9 weeks after spinal cord injury. 
The dogs were sedated with IV administration of diazepam 
(Dong Wha Pharm, Korea) at a dose of 0.2 mg/kg immediately 
followed by IV morphine at 0.3 mg/kg. The dogs were 
induced with IV administration of propofol (Ha Na Pharm, 
Korea) at 6 mg/kg. After tracheal intubation, anesthesia was 
maintained by isoflurane (Ilisung, Korea) in oxygen. The 
dogs were euthanized by pentobarbital sodium (Han Lim 
Pharm, Korea) at 80 mg/kg and bolus injection of 10 mL 
KCl solution (1 M) into the cephalic vein. The spinal cords 
from T10 to L4 of all dogs were sampled. Spinal cords 
were fixed in 20% sucrose solution overnight at 4
oC. Dura 
were removed by scissors, embedded using O.C.T compound 
(Sakura Finetechnical, Japan), frozen and transversely 
sectioned at epicenter of lesion. These sections were 
mounted on silanecoated glass slides. 
Slides were stained first with hematoxylin and eosin, and 
then with combined Luxol fast blue and cresyl violet to 
identify myelin and nerve cells [10]. Percentages of 
myelinated areas in damaged spinal cords were calculated 
using the formula, (myelinated areas/total area) × 100, 
from images of the transverse sections using image 
analyzer software (ImageJ version 1.37; National Institutes 
of Health, USA). Longitudinal sections were made with 
tissue in which GFP-labeled lentiviral vector inserted stem 
cells were injected. Primary antibodies were used against 
mature astrocytes (GFAP, AB5804; Chemicon International, 
USA), immature neurons (TUJ1-β, ab14545; Abcam, 
UK), motor neurons (NF160, N5264; Sigma, USA), and 
oligodendrocytes (Oligodendrocyte marker, MAB5540; 
Chemicon International, USA) for immunofluorescent 
determinations of the phenotypes of GFP (+) cells. Tissues 
were incubated in goat serum for 2 h at room temperature. 
The tissues were then incubated with the primary 
antibodies for 24 h at 4
oC. Secondary antibodies (anti- 
mouse fluro 588, anti-rabbit fluro 588; Invitrogen, USA) 
were used against primary antibodies. DAPI (1 : 100; Transplantation of ASCs in spinal cord injury    277
Fig. 3. Flow cytometric analysis of surface-marker expression on ASC. The seventh passage of ASCs expressed CD44, CD90 and 
CD105, and were negative for CD14, CD34, CD45. The overwhelming majority (＞ 95%) of cASC expressed the mesenchymal cell
surface markers CD90 and CD105.
Sigma, USA) was added to a final wash to identify nuclei. 
Tissues were mounted with aqueous mounting medium 
(Dakocytomation, USA) and kept in the dark at 򰠏4
oC until 
analysis. Slide images were obtained by confocal microscopy 
(Nikon, Japan). 
Statistical analysis
Results were expressed as medians for Olby scores and 
the means ± SD for SEP values and Luxol fast blue positive 
areas. Statistical analysis used SPSS 12.0 software (SPSS, 
USA). Kruskal-Wallis analysis for Olby scores and one- 
way ANOVA for SEP values and Luxol fast blue positive 
areas were used. p-value ＜ 0.05 was considered significant.
Results
Differentiation test of ASCs
Adipogenic differentiation of ASCs was apparent after 3 
weeks of incubation with adipogenic medium. By the end 
of the third week, half of the cells contained Oil red 
O-positive lipid droplets (Fig. 1B). The colonies of ASCs 
were subjected to Alizarin red S staining 3 weeks after the 
initiation of osteogenic differentiation. Intense Alizarin 
red S staining of the colonies confirmed that calcium 
deposition had occurred (Fig. 1D). After ASCs were 
induced into neurogenic differentiation, cells stained 
positive for the neuronal marker MAP2 and were negative 
for the undifferentiated marker Oct-4 during neuronal 
differentiation in vitro. 
Characterization of ASCs
The first passage of ASCs expressed CD44, CD90, CD105 
and MHC class I, and were also partially positive for CD34. 
They did not express CD14 or CD45. The seventh passage 
of ASCs expressed CD44, CD90 and CD105, and were 
negative for CD14, CD34, CD45 (Fig. 3).278    Hak-Hyun Ryu et al.
Fig. 4. Olby scores during the 9 week post-SCI study period. 
The scores in ASC group were significantly higher than these in 
the other two groups at 5 and 9 weeks after spinal cord injury (*p
＜ 0.05). 
Behavioral outcomes
Olby scores for all groups were 0 points post-SCI, at the 
start of treatment. The scores for the ASC group increased 
to 1, 3.6 and 4.6 points at 3, 5 and 9 weeks, respectively 
(Fig. 4). Scores in the C and V groups remained below 1 
point up to the end of the study. Scores for the ASC group 
were significantly higher than those for the C and V groups 
at 5 weeks (p <　0.05). There were no significant differences 
between the C and V groups.
Somatosensory evoked potentials
It was possible to measure evoked potentials in the ASC 
group 5 weeks post-injury. The C and V groups had no 
responses at to 9 weeks. Mean conduction velocities in the 
ASC group were 22.8 ± 10.9 m/sec at 5 weeks and 31.1 ± 
12.2 m/sec at 9 weeks. 
MRI
MRI scans were well tolerated by all dogs. The majority 
of dogs in all groups showed clear, hyper-intense signals in 
the T2W sagittal plane of the lesion at the 1st lumbar 
vertebra (L1) at 1 week and 5 weeks after SCI. T2W 
images showed reduction of swelling and hyperintense 
signal at 9 weeks in all groups. These hyper-intense signals 
were not different among groups (Fig. 5). 
Histopathological findings
Margins for gray and white matters were not identified in 
any of the dogs at 9 weeks (Figs. 5 and 7). There were 
generalized infiltrations of fibrous tissues and adhesions in 
the dura mater. Most dogs had mild vacuolar formations. 
Cavitation of the gray matter was seen within cranial and 
caudal lesions of the SCI site. The areas positively stained 
Luxol fast blue in the ASC group were larger than those in 
other groups. The mean percentages of Luxol fast blue 
positive areas in the C, V and ASC groups were 16.66 ± 
2.41%, 17.06 ± 2.85% and 31.16 ± 3.13%, respectively 
(p ＜ 0.05) (Fig. 6). High magnification revealed neuronal 
cell like structures. GFP positive cells were stained by 
Tuj-1 in serial transverse sections (Fig. 7). In longitudinal 
sections of the lesion, GFP positive cells were observed 
and were also positive for GFAP, NF160, Tuj-1 and 
oligodendrocytes (Fig. 8).
Discussion
The SVF contains an unpurified population of stromal 
cells, which includes ASCs. The other cell types that may 
be present in SVF are endothelial cells, smooth muscle 
cells, pericytes, fibroblasts, and circulating cell types such 
as leucocytes, hematopoietic stem cells or endothelial 
progenitor cells [44]. Many studies have used the entire 
unpurified SVF in their experiments on the basis that the 
ASC are adherent to the plastic tissue cultureware, so they 
are self-selected out of the SVF during subsequent tissue 
culture passages [27]. As few as one in 30 of the SVF cells 
adhere to the plastic [25], and there is a progressive loss of 
hematopoietic lineage cell markers (such as CD11, CD14 
and CD45) with successive cultures of ASC [25]. Adherence 
to plastic tissue cultureware, however, is not a feature that 
is specific to ASCs because fibroblast cells also behave in 
this manner. Some critics have suggested that even a low 
fraction of contaminating cells such as hematopoietic stem 
cells could be the source of differentiation seen in ASC 
experiments [32]. Purification by magnetic bead coupling 
has been performed [4] to remove CD45
+ cells (leucocytic/ 
hematopoietic lineage) and CD31
+ cells (endothelial 
lineage) from the isolated cells prior to differentiation 
experiments. Given the relative simplicity of such sorting 
procedures, it would seem reasonable to advocate that 
ASCs should be purified from the SVF before cell culture. 
In our study, adipose tissue culture yielded an adherent 
growing cell population with a spindle morphology. Flow 
cytometric analysis revealed high levels of CD44, CD90 
and CD105 expression whereas the expression of CD- 
proteins typical for hematopoietic cells remained undetectable. 
It identified ASCs as partially positive for CD34 in SVF 
preparation, but this marker is subsequently lost during in 
vitro culture [4]. These findings suggested the presence of 
mesenchymal stem cell-like cells according to the standard 
criteria for MSCs from the International  Society for 
Cellular Therapy [8]. Moreover, a distinct subpopulation 
of the ASCs demonstrated the potential to differentiate into 
adipocyte, osteocyte, and neuron-like cells.
SCI has been investigated by using various experimental 
models such as weight drop [23], pneumatic impaction 
[1], and extradural balloon compression [19]. The major 
factor in the pathogenesis of SCI produced by the weight 
dropping method was mechanical, whereas both mechanical 
and vascular factors were involved in balloon compression Transplantation of ASCs in spinal cord injury    279
Fig. 5. Images of the spinal cord injury lesion. A: control group with no ASCs transplantation.  B: vehicle group with PBS. C and D:
ASC group with transplantation with ASCs. Sagittal image: a, b, c and d. T1-weighted MR image at 5 weeks (a), T2-weighted MR 
image at 5 weeks (b), T1-weighted MR image at 9 weeks (c), T2-weighted MR image at 9 weeks (d). White arrowhead indicated the
cranial, center and caudal portions of the transverse image. Transverse, T1-weighted MR image at 5 weeks (T1) and transverse, 
T2-weighted MR image at 5 weeks (T2). Black arrow indicated cavitation. The hyperintense lesions in T2-weighted MR image at 5
and 9 weeks after spinal cord injury were not different among groups.
methods. Balloon compresses the spinal cord and produces 
a closed injury without laminectomy at the injury site, and 
thus it resembles injuries observed in clinical cases of, for 
example, unreduced dislocation, intervertebral disc disease 
or fracture dislocation [10]. The balloon-induced method 
has been used because it is a simple method that does not 
cause any damage to the surrounding structures and dose- 
response based on volume of the balloon and degree of 
injury occurs in rats and dogs [36]. Our method of drilling 
a mini hemi-laminectomy hole for insertion of a balloon 280    Hak-Hyun Ryu et al.
Fig. 6. Percentage of luxol fast blue staining positive areas in 
the transverse sections at the epicenters of injured spinal cords. 
Luxol fast blue positive areas in the control group and vehicle 
group were smaller than those in the ASC group. *p ＜ 0.05 
compared to control gruop, 
†p ＜ 0.05 compared to vehicle 
group.
Fig. 7. Histopathological findings 9 weeks after spinal cord injury. A and D: group C; B and E : group V; C, F-H: group ASC. All 
groups showed extensively damaged tissues. F: Positive areas for Luxol fast blue staining were observed at injured sites in the ASC
group (circles). G and H: These showed structural consistency with nerve cell. A, B and C: H&E stain, D-G: Luxol fast blue and cresyl
violet stain, H, H1, H2 and H3: Immunofluorescence staining. Scale bars = 50 μm.
catheter provided easy exposure of dura mater with no risk 
of hemorrhage in a relatively short time (30 min). 
In this study, the SCI model resulted in over 75% spinal 
canal occlusion by balloon compression over 12 h. Severe 
hemorrhage and vacuolar formation occurred 1 week after 
SCI and generalized infiltration of fibrous tissue was seen 
9 weeks post-injury and no functional improvement in 
control group were observed. Similar histopathological 
findings at 9 weeks have been previously reported [22]. 
Margins for gray and white matter were not identified in 
any of the dogs at 9 weeks post-injury. There were 
generalized infiltrations of fibrous tissues and adhesions in 
the dura mater. Most dogs had mild vacuolar formations. 
Cavitation of the gray matter was seen within cranial and 
caudal lesions of the SCI site. Vacuolar formations and 
cavitation acted as a physical barrier to the growth of 
anatomically intact axons. There were no myelinated 
axons and normal neurons in epicenter of SCI lesions in all 
dogs. 
Classically, the Tarlov scale has been used for the 
quantitative evaluation of neurological status resulting 
from spinal cord injury in dogs [31]. Basso-Bresnahan- 
Beattie (BBB) score for rodents or modification of the 
Tarlov scale also have been used [20], but those scoring 
systems were not sensitive enough to describe the details of 
functional status due to the large variations resulting from 
the broad category of each level. Olby et al. [28] modified 
the BBB open field scoring system for dogs based on the 
pelvic limb gait of dogs with SCI resulting in thoraco-
lumbar vertebral disc herniations. The pelvic limb gaits of 
dogs who recover from SCI can be reliably quantified with 
a numeric scale, namely, the Olby score [28]. In our study, Transplantation of ASCs in spinal cord injury    281
Fig. 8. Immunofluorescence staining of ASC group;  A1-A3: Glial  fibrillary acidic protein (GFAP), B1-B3: Neurofilament M (NF160),
C1-C3: Neuronal class III beta tubulin (Tuj-1), D1-D3: Oligodendrocyte, Green fluorescence protein (GFP)- labeled lentiviral vector inserted
stem cells were positive with GFAP, NF 160, Tuj-1, and oligodendrocytes in injured lesions (arrows). Scale bars = 50 μm.
dogs had Olby scores ＜ 1 up to 9 weeks after injury in the 
C and V groups. An Olby score of 1 is defined as a 
neurological status for which there is no pelvic limb 
movement and with deep pain sensation. The Olby score 
for the ASC group increased in the 9 weeks after injury and 
was 4.6 at the end of the study, with moveable joints of the 
pelvic limbs. This score at 9 weeks was lower than that a 
previous report (Olby score; 7.4) that used umbilical cord 
blood-derived stem cells [22]. 
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and latencies have been associated with the severity of 
spinal cord damage in experimentally induced SCI [29]. 
SEP conduction velocities in dogs with mild spinal cord 
lesions were lower than those in normal dogs [29]. The 
SEP has a flat waveform when the spinal cord is injured by 
more than 50% [21]. The neurological status of the C and 
V groups was consistent with a flat waveform up to 9 
weeks post-injury. The mean conduction velocity in the 
ASC group at 9 weeks was 31.1 ± 12.2 m/sec, which is 
approximately 50% lower than that in normal dogs [41]. 
MRI is a useful and powerful tool in detection and 
characterization of spinal cord pathology in animal models 
[3,38]. T1 weighted images were considered most useful 
for assessment of cord swelling and hemorrhage, and T2 
weighted images were valuable for assessment of fluid 
infiltration into the cord, i.e. edema [24]. Cord swelling 
occurs due to disruption of vasculature and alteration of 
local fluid compartmentalization, with subsequent accu-
mulation of blood and edema in and around the site of the 
contusion injury [9]. The hypointense areas in the L1 
parenchyma on T2W images could be considered a black 
boundary artifact [24]. The hyperintense lesions at 5 and 9 
weeks after transplantation were not different among 
groups. Our MRI settings were useful for the identification 
of localized spinal cord lesions. However, they were not 
sufficient to show changes of spinal cord lesions in the 
chronic phase.
In vivo MSC studies have demonstrated the cellular fate 
of cells which integrated into injured spinal cord [33]. 
Recent reports have suggested that ASCs survived and 
migrated to injured CNS tissue after transplantation [17], 
and transplanted MSCs express GFAP or neuronal nuclear 
antigen in the ischemic brain [43]. In this study, GFP- 
labeled stem cells inserted with lentiviral vectors were 
positive for GFAP, NF160, Tuj-1, and an oligodendrocyte 
marker in spinal cord lesions. This suggested that the 
implanted ASCs differentiated into astrocytes and oligo-
dendrocytes, as well as neuronal cells. Neurons derived 
from engrafted cells may relay signals from disrupted 
fibers in the host, including local circuit interneurons or 
ascending fibers that are present in the dorsal column [5]. 
The neuronal transdifferentiation processes seen for 
ASCs may result from the interactions of cells, cytokines 
provided by these cells, growth factors and intercellular 
signals [6]. ASCs have been shown to secrete multiple 
angiogenic and anti-apoptotic cytokines that support tissue 
regeneration and minimize tissue damage [30]. Engrafted 
ASCs and SCI-induced chemotactic factors play important 
roles in proliferation, migration and differentiation of 
endogenous spinal cord-derived neural progenitor cells in 
an injured region [18]. Those MSCs that survived 
produced large amounts of basic fibroblast growth factor 
and vascular endothelial growth factor receptor 3 in the 
host spinal cord [40]. 
In conclusion, these results suggest that improvements of 
neurological function after transplantation of ASCs to 
dogs with spinal cord injuries might be partially due to 
neural differentiation of implanted stem cells. 
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